NettetHoau-Yan Wang, Ph.D. Impact: PTI-125 is a clinical-stage small molecule drug candidate to treat Alzheimer’s disease derived from collaborative work with Pain Therapeutics, Inc. (Austin, Texas). PTI-125 has a novel mechanism of action: it binds an altered shape of the scaffolding protein and restores its normal shape. Nettet26. apr. 2024 · April 26, 2024 . Letter To Science Editor of the New York Times: Regarding The New York Times article, “Scientists Question Data Behind an Experimental Alzheimer’s Drug”, by Apoorva Mandavilli (April 18, 2024): we’re disappointed the reporter relied almost exclusively on sources known to be critical of Cassava Sciences, failed to …
Hoau-Yan Wang - Tenured Associate Medical Professor - LinkedIn
Nettet4. feb. 2024 · Shaowei Wang 1, Boyang Li 1, Victoria Solomon 1, Alfred Fonteh 2, Stanley I. Rapoport 3, David A. Bennett 4, Zoe Arvanitakis 4, Helena C. Chui 1, Carol Miller 1, Patrick M. Sullivan 5, Hoau-Yan Wang 6,7 & … Hussein N. Yassine 1 Show authors. Molecular Neurodegeneration volume 17, Article number: 14 (2024) Cite this article NettetKonrad Talbot;Hoau-Yan Wang;Hala Kazi;Li-Ying Han. Journal of Clinical Investigation (2012) 1343 Citations Loneliness and Risk of Alzheimer Disease. Robert S. Wilson;Kristin R. Krueger;Steven E. Arnold;Julie A. Schneider. Archives of … streaming film london love story 1
Potential fabrication in research images threatens key theory of ...
Nettet19. jan. 2024 · Info & Metrics. eLetters. PDF. JNeurosci is publishing an Expression of Concern for the article, “Reducing Amyloid-Related Alzheimer's Disease Pathogenesis … Nettet26. sep. 2024 · It’s bad, but somehow it gets much, much worse. In June 2024, Alzheimer’s Research and Therapy made the editorial decision to retract a 2024 paper by Wang with the explanation that “the authors have provided the raw data, which have been assessed by independent experts and deemed insufficient to address the concerns.”. Nettet2. jun. 2024 · Published: Jun 02, 2024 By Alex Keown. Cassava Sciences is reeling after another journal retracted an article co-authored by a key collaborator on its experimental Alzheimer's disease therapeutic, simufilam. On Wednesday, the science publication Springer pulled the article "Increased Aβ42-α7-like nicotinic acetylcholine receptor … rowan water caravan park